|   | 
Details
   web
Records
Author (up)
Title 2012 drug packaging review: many dangerous, reportable flaws Type Journal Article
Year 2013 Publication Prescrire International Abbreviated Journal Prescrire Int
Volume 22 Issue 138 Pages 134-137
Keywords Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Child; Drug Industry/legislation & jurisprudence; Drug Labeling; Drug Packaging/*standards/trends; Female; Humans; Patient Education as Topic; Pediatrics/legislation & jurisprudence; Poisoning/prevention & control; Pregnancy
Abstract Drug packaging plays an important role in protecting and providing information to patients. The packaging examined by Prescrire in 2012, on the whole, still fails to perform all of these functions effectively. Two issues are especially worrisome. First, packaging too often poses a danger to children. In addition, too many patient leaflets provide incomplete information about adverse effects, thus failing to properly protect the most vulnerable patients. Yet, the method Prescrire used to analyse drug packaging shows that it is not difficult to detect and anticipate risks. It is up to healthcare professionals to take advantage of the method, to protect patients from, and report, dangerous packaging.
Address
Corporate Author Thesis
Publisher Place of Publication Editor
Language English Summary Language Original Title
Series Editor Series Title Abbreviated Series Title
Series Volume Series Issue Edition
ISSN 1167-7422 ISBN Medium
Area Expedition Conference
Notes PMID:23819184 Approved no
Call Number ref @ user @ Serial 87926
Permanent link to this record
 

 
Author (up)
Title 2012 drug packaging review: many dangerous, reportable flaws Type Journal Article
Year 2013 Publication Prescrire International Abbreviated Journal Prescrire Int
Volume 22 Issue 138 Pages 134-137
Keywords Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Child; Drug Industry/legislation & jurisprudence; Drug Labeling; Drug Packaging/*standards/trends; Female; Humans; Patient Education as Topic; Pediatrics/legislation & jurisprudence; Poisoning/prevention & control; Pregnancy
Abstract Drug packaging plays an important role in protecting and providing information to patients. The packaging examined by Prescrire in 2012, on the whole, still fails to perform all of these functions effectively. Two issues are especially worrisome. First, packaging too often poses a danger to children. In addition, too many patient leaflets provide incomplete information about adverse effects, thus failing to properly protect the most vulnerable patients. Yet, the method Prescrire used to analyse drug packaging shows that it is not difficult to detect and anticipate risks. It is up to healthcare professionals to take advantage of the method, to protect patients from, and report, dangerous packaging.
Address
Corporate Author Thesis
Publisher Place of Publication Editor
Language English Summary Language Original Title
Series Editor Series Title Abbreviated Series Title
Series Volume Series Issue Edition
ISSN 1167-7422 ISBN Medium
Area Expedition Conference
Notes PMID:23819184 Approved no
Call Number ref @ user @ Serial 88497
Permanent link to this record
 

 
Author (up)
Title 2012 drug packaging review: many dangerous, reportable flaws Type Journal Article
Year 2013 Publication Prescrire International Abbreviated Journal Prescrire Int
Volume 22 Issue 138 Pages 134-137
Keywords Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Child; Drug Industry/legislation & jurisprudence; Drug Labeling; Drug Packaging/*standards/trends; Female; Humans; Patient Education as Topic; Pediatrics/legislation & jurisprudence; Poisoning/prevention & control; Pregnancy
Abstract Drug packaging plays an important role in protecting and providing information to patients. The packaging examined by Prescrire in 2012, on the whole, still fails to perform all of these functions effectively. Two issues are especially worrisome. First, packaging too often poses a danger to children. In addition, too many patient leaflets provide incomplete information about adverse effects, thus failing to properly protect the most vulnerable patients. Yet, the method Prescrire used to analyse drug packaging shows that it is not difficult to detect and anticipate risks. It is up to healthcare professionals to take advantage of the method, to protect patients from, and report, dangerous packaging.
Address
Corporate Author Thesis
Publisher Place of Publication Editor
Language English Summary Language Original Title
Series Editor Series Title Abbreviated Series Title
Series Volume Series Issue Edition
ISSN 1167-7422 ISBN Medium
Area Expedition Conference
Notes PMID:23819184 Approved no
Call Number ref @ user @ Serial 88862
Permanent link to this record
 

 
Author (up)
Title 2012 drug packaging review: many dangerous, reportable flaws Type Journal Article
Year 2013 Publication Prescrire International Abbreviated Journal Prescrire Int
Volume 22 Issue 138 Pages 134-137
Keywords Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Child; Drug Industry/legislation & jurisprudence; Drug Labeling; Drug Packaging/*standards/trends; Female; Humans; Patient Education as Topic; Pediatrics/legislation & jurisprudence; Poisoning/prevention & control; Pregnancy
Abstract Drug packaging plays an important role in protecting and providing information to patients. The packaging examined by Prescrire in 2012, on the whole, still fails to perform all of these functions effectively. Two issues are especially worrisome. First, packaging too often poses a danger to children. In addition, too many patient leaflets provide incomplete information about adverse effects, thus failing to properly protect the most vulnerable patients. Yet, the method Prescrire used to analyse drug packaging shows that it is not difficult to detect and anticipate risks. It is up to healthcare professionals to take advantage of the method, to protect patients from, and report, dangerous packaging.
Address
Corporate Author Thesis
Publisher Place of Publication Editor
Language English Summary Language Original Title
Series Editor Series Title Abbreviated Series Title
Series Volume Series Issue Edition
ISSN 1167-7422 ISBN Medium
Area Expedition Conference
Notes PMID:23819184 Approved no
Call Number ref @ user @ Serial 89433
Permanent link to this record
 

 
Author (up)
Title 2012 drug packaging review: many dangerous, reportable flaws Type Journal Article
Year 2013 Publication Prescrire International Abbreviated Journal Prescrire Int
Volume 22 Issue 138 Pages 134-137
Keywords Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Child; Drug Industry/legislation & jurisprudence; Drug Labeling; Drug Packaging/*standards/trends; Female; Humans; Patient Education as Topic; Pediatrics/legislation & jurisprudence; Poisoning/prevention & control; Pregnancy
Abstract Drug packaging plays an important role in protecting and providing information to patients. The packaging examined by Prescrire in 2012, on the whole, still fails to perform all of these functions effectively. Two issues are especially worrisome. First, packaging too often poses a danger to children. In addition, too many patient leaflets provide incomplete information about adverse effects, thus failing to properly protect the most vulnerable patients. Yet, the method Prescrire used to analyse drug packaging shows that it is not difficult to detect and anticipate risks. It is up to healthcare professionals to take advantage of the method, to protect patients from, and report, dangerous packaging.
Address
Corporate Author Thesis
Publisher Place of Publication Editor
Language English Summary Language Original Title
Series Editor Series Title Abbreviated Series Title
Series Volume Series Issue Edition
ISSN 1167-7422 ISBN Medium
Area Expedition Conference
Notes PMID:23819184 Approved no
Call Number ref @ user @ Serial 90004
Permanent link to this record